ProQR Therapeutics N.V. (PRQR) PT Lowered to $8 at JMP Securities
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/4/2026
- Wall St futures jump as Democrats sweep midterms
- CVS Health plans to split into two public companies by 2028
- UBS starts bullish coverage on Ferrari Group on luxury logistics growth
- Citi cuts Adobe rating on ’rising risk of a hard reset’
- Apple shares slip amid guidance for tightening margins, slowing services growth
Tweet
Share
E-mailGet Alerts PRQR Hot Sheet
Price: $1.37 --0%
Rating Summary:
13 Buy, 2 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 15 | Down: 20 | New: 12
Rating Summary:
13 Buy, 2 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 15 | Down: 20 | New: 12
Join SI Premium – FREE
JMP Securities analyst Jonathan Wolleben lowered the price target on ProQR Therapeutics N.V. (NASDAQ: PRQR) to $8.00 (from $29.00) while maintaining a Market Outperform rating.
You May Also Be Interested In
- Fortis Inc. (FTS:CN) (FTS) PT Raised to Cdn$90 at RBC Capital
- Yum! Brands (YUM) PT Raised to $180 at RBC Capital
- Louisiana-Pacific Corp (LPX) PT Raised to $85 at RBC Capital
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
